NCT06317389View on ClinicalTrials.gov

PACOME (PAtient Cancer Oral MEdication) Cohort of Patients Treated With Oral Anticancer Drugs Benefiting From Oncoral Multidisciplinary Monitoring in Real Life: Predictive Factors and Safety of Treatments

RecruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

June 23, 2025

Primary Completion Date

July 31, 2035

Study Completion Date

July 31, 2037

Conditions
CancerOncologyOncoral Program
Interventions
OTHER

Questionnaires

Patients will benefit of supervision by the ONCORAL team in the usual way and their intervention will be limited to completing questionnaires.

Trial Locations (1)

69495

RECRUITING

Groupement Hospitalier Sud - Unité de Pharmacie Clinique Oncologique, Pierre-Bénite

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER